Investing.com - Repligen (NASDAQ:RGEN) reported on Tuesday third quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Repligen announced earnings per share of $0.77 on revenue of $200.7M. Analysts polled by Investing.com anticipated EPS of $0.68 on revenue of $192.68M.
Repligen shares are down 31% from the beginning of the year, still down 40.55% from its 52 week high of $306.98 set on November 2, 2021.
Repligen shares lost 5.75% in pre-market trade following the report.
Repligen follows other major Healthcare sector earnings this month
Repligen's report follows an earnings beat by UnitedHealth on October 14, who reported EPS of $5.79 on revenue of $80.9B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on October 18 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar